Pfizer to sell infusion business to ICU MedicalStaff Writer | October 7, 2016
Pfizer said it would sell its global infusion therapy business to ICU Medical Inc for $1 billion in cash and stock that will give it a major stake in the smaller company.
Pharma Pfizer will receive $600 million in cash
But Pfizer said in July it was exploring the possible sale of the infusion products to focus on its core pharmaceuticals business.
Pfizer will receive $600 million in cash and nearly $400 million in newly issued shares of ICU Medical, giving it a stake of about 16.6 percent in the company. ■